M. Mandal, J. Am. Chem. Soc., 2002, 124, 6538–6539; (g) H. Kawai,
A. Kusuda, S. Nakamura, M. Shiro and N. Shibata, Angew. Chem.,
Int. Ed., 2009, 48, 6324–6327; (h) F. Massicot, J. Nonnenmacher,
F. Grellepois and C. Portella, Eur. J. Org. Chem., 2010, 275–279;
(i) D. A. Nagib, M. E. Scott and D. W. C. MacMillan, J. Am. Chem.
Soc., 2009, 131, 10875–10877; (j) A. E. Allen and D. W. C.
MacMillan, J. Am. Chem. Soc., 2010, 132, 4986–4987;
(k) S. Fustero, D. Jimenez, J. F. Sanz-Cervera, M. Sanchez-Rosello,
E. Esteban and A. Simon-Fuentes, Org. Lett., 2005, 7, 3433–3436;
(l) X.-J. Wang, Y. Zhao and J.-T. Liu, Org. Lett., 2007, 9,
1343–1345; (m) J. Nie, G.-W. Zhang, L. Wang, A. Fu, Y. Zheng
and J.-A. Ma, Chem. Commun., 2009, 2356–2358.
4 (a) S. Marcotte, X. Pannecoucke, C. Feasson and J.-C. Quirion,
J. Org. Chem., 1999, 64, 8461–8464; (b) G. B. Evans,
R. H. Furneaux, A. Lewandowicz, V. L. Schramm and
P. C. Tyler, J. Med. Chem., 2003, 46, 3412–3423; (c) D. D. Staas,
K. L. Savage, C. F. Homnick, N. N. Tsou and R. G. Ball, J. Org.
Chem., 2002, 67, 8276–8279; (d) Y. Li and J. Hu, Angew. Chem.,
Int. Ed., 2005, 44, 5882–5886; (e) Y. Li and J. Hu, Angew. Chem.,
Int. Ed., 2007, 46, 2489–2492; (f) M. Braun, A. Vonderhagen and
D. Waldmfiller, Liebigs Ann., 1995, 1447–1450; (g) K. Iseki,
Y. Kuroki, D. Asada and Y. Kobayashi, Tetrahedron Lett.,
1997, 38, 1447–1448; (h) K. Iseki, Y. Kuroki, D. Asada,
M. Takahashi, S. Kishimoto and Y. Kobayashi, Tetrahedron,
1997, 53, 10271–10280.
5 (a) D. Paris, M. Cottin, P. Demonchaux, G. Augert,
P. Dupassieux, P. Lenoir, M. J. Peck and D. Jasserand, J. Med.
Chem., 1995, 38, 669–685; (b) Y. Xia, Z.-Y. Yang, P. Xia,
K. F. Bastow, Y. Tachibana, S.-C. Kuo, E. Hamel, T. Hackl
and K.-H. Lee, J. Med. Chem., 1998, 41, 1155–1162.
6 (a) B. Crousse, J.-P. Begue and D. Bonnet-Delpon, Tetrahedron
Lett., 1998, 39, 5765–5768; (b) B. Crousse, J.-P. Begue and
D. Bonnet-Delpon, J. Org. Chem., 2000, 65, 5009–5013.
7 For recent reviews, see: (a) T. Akiyama, J. Itoh and K. Fuchibe,
Adv. Synth. Catal., 2006, 348, 999–1010; (b) T. Akiyama, Chem.
Rev., 2007, 107, 5744–5758; (c) M. Terada, Chem. Commun., 2008,
4097–4112; (d) S.-L. You, Q. Cai and M. Zeng, Chem. Soc. Rev.,
2009, 38, 2190–2201; (e) M. Terada, Synthesis, 2010, 12,
1929–1982; (f) M. Terada, Curr. Org. Chem., 2011, 15, 2227–2256.
8 (a) T. Akiyama, H. Morita and K. Fuchibe, J. Am. Chem. Soc.,
2006, 128, 13070–13071; (b) H. Liu, G. Dagousset, G. Masson,
P. Retailleau and J. Zhu, J. Am. Chem. Soc., 2009, 131, 4598–4599;
(c) G. Dagousset, J. Zhu and G. Masson, J. Am. Chem. Soc., 2011,
133, 14804–14813; (d) G. Bergonzini, L. Gramigna, A. Mazzanti,
M. Fochi, L. Bernardi and A. Ricci, Chem. Commun., 2010, 46,
327–329.
9 (a) A. D. Becke, J. Chem. Phys., 1993, 98, 5648–5652; (b) C. T. Lee,
W. T. Yang and R. G. Parr, Phys. Rev. B, 1988, 37, 785–789;
(c) P. C. Hariharan and J. A. Pople, Theor. Chim. Acta, 1973, 28,
213–222; (d) M. M. Francl, W. J. Pietro, W. J. Henre, J. S. Binkley,
M. S. Gordon, D. J. DeFrees and J. A. Pople, J. Chem. Phys.,
1982, 77, 3654–3665.
Fig. 3 The proposed reaction mechanism.
a chiral phosphoric acid. The results presented here provide a
versatile platform for the asymmetrical synthesis of tetrahydro-
quinoline derivatives with potential interesting bioactivities.
Studies to apply the chiral phosphoric acid to other enantioen-
riched CF3- or –CF2-group substituted compounds are currently
underway.
We thank the National Natural Science Foundation (21032006,
21172240), the 973 Program of China (2012CBA01200) and the
Chinese Academy of Sciences for financial support.
Notes and references
1 (a) R. E. Banks, B. E. Smart and J. C. Tatlow, Organofluorine
Chemistry: Principles and Commercial Applications, Plenum Press,
New York, 1994; (b) R. D. Chambers, Fluorine in Organic
Chemistry, Blackwell Publishing Ltd, 2004; (c) K. Uneyama,
Organofluorine chemistry, Blackwell Publishing Ltd, 2006.
2 (a) O. S. Pedersen and E. B. Pedersen, Synthesis, 2000, 4, 479–495;
(b) V. A. Soloshonok, K. Mikami, T. Yamazaki, J. T. Welch and
J. F. Honek, Current Fluoroorganic Chemistry, American Chemical
Society, Washington, 2007, pp. 305–322; (c) J.-P. Begue and
D. Bonnet-Delpon, Bioorganic and Medicinal Chemistry of Fluorine,
Wiley, New Jersey, 2008.
3 For reviews, see: (a) J.-A. Ma and D. Cahard, Chem. Rev., 2004,
104, 6119–6146; (b) T. Billard and B. R. Langlois, Eur. J. Org.
Chem., 2007, 891–897; (c) N. Shibata, S. Mizuta and H. Kawai,
Tetrahedron: Asymmetry, 2008, 19, 2633–2644; (d) G. Valero,
X. Companyo and R. Rios, Chem.–Eur. J., 2011, 17, 2018–2037;
For examples, see: (e) G. K. S. Prakash, M. Mandal and G. A. Olah,
Angew. Chem., Int. Ed., 2001, 40, 589–590; (f) G. K. S. Prakash and
10 (a) D. Bello, R. Ramon and R. Lavilla, Curr. Org. Chem., 2010, 14,
332–356; (b) H. Xie, J. Zhu, Z. Chen, S. Li and Y. Wu, Synlett,
2010, 2659–2663.
c
7740 Chem. Commun., 2012, 48, 7738–7740
This journal is The Royal Society of Chemistry 2012